Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.

HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.

Bay Area drug discovery company Verge Genomics has formed industry and academic alliances in neuro disorders.

Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.

Janssen has developed a mobile toolkit for trial supply management and patient engagement that can track adherence to each pill.

Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.

Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.

The deal gives Boehringer access to Gubra’s expertise in the design, synthesis and preclinical testing of therapeutic peptides.

The multiyear agreement positions Lilly to work with Topas on drugs that convey tolerance to antigens linked to inflammation or autoimmune diseases.